![]() 2026 SDHF CME Symposium - Best Practices for Screening, Diagnosing and Treating Transthyretin Amyloid Cardiomyopathy (ATTR-CM)This CME Symposium takes place on Friday, July 10, 2026, from 3:55 PM - 4:55 PM PT during the 2026 San Diego Heart Failure Summer Symposium in San Diego, California.
By: CMEPlanet Click here for more information CHAIR Marcus Anthony Urey, MD Associate Professor of Medicine UC San Diego Health San Diego, California FACULTY Ahmad Masri, MD, MS Associate Professor of Medicine Oregon Health and Sciences University Portland, Oregon Ronald Witteles, MD Professor of Medicine (Cardiovascular Medicine) Stanford University School of Medicine Stanford, California Educational Objectives ■ Identify clinical clues that suggest the possibility for an ATTR-CM diagnosis. ■ Explain key steps in the diagnostic algorithm for ATTR-CM. ■ Describe the clinical evidence for ATTR-CM disease-modifying therapies, best adjustments of HF GDMT in patients with ATTR-CM, and novel therapies in development. Target Audience This educational activity is intended for cardiovascular clinicians. Accreditation and Credit Designation Statements Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. End
|